Increasing evidence has highlighted the enhancement of high expression COX2 on cell proliferation, apoptosis inhibition, immune evasion, and chemotherapy resistance, which contributes to hepatocarcinogenesis and reduced survival of patients with HCC (25, 26). Here, PTGS2 is linked to hepatocellular carcinoma.